Food Allergy Canada—the community-based advocacy, information, education and research organization and valued AllerGen partner—has launched a new online training course for parents and caregivers entitled: “Anaphylaxis in the Community: What Parents and Others Need to Know.” Developed with Leap Learning Technologies …

AllerGen partner launches new anaphylaxis training course Read more »

Dr. Howard Bergman, Chair of AllerGen’s Board of Directors, recently led celebrations to mark the 40th anniversary of the Department of Family Medicine at McGill University. “When the family medicine program started at McGill University 40 years ago, there was …

AllerGen Board Chair leads celebration of 40 years of Family Medicine at McGill Read more »

How many Canadians visit emergency departments (ED) each year due to allergic reactions and anaphylaxis? Are the numbers growing? Which months are the most common for anaphylactic emergencies? How have prescription patterns for epinephrine auto-injectors changed over time? A new …

New report on Canadian anaphylaxis and allergic reactions in the emergency department Read more »

AllerGen research leader Dr. Paul O’Byrne has been appointed to the newly created Pulmonary Medical Advisory Board of Hydra Biosciences, a Massachusetts-based biopharmaceutical company that develops drugs to treat pain, inflammation, renal disease, anxiety and pulmonary disease. Dr. O’Byrne, a …

AllerGen researchers appointed to Hydra Biosciences Advisory Board Read more »

A new consensus communication—issued jointly by Canadian, American and European allergists and the World Allergy Organization—recommends introducing peanut-containing products into the diet of “high risk” infants between four and 11 months of age. The Canadian Society of Allergy & Clinical …

Canadian allergists recommend early peanut introduction for “high risk” infants Read more »